Specialty Infusion only administers FDA approved brand and generic pharmaceuticals sourced from reputable U.S. distributors.
and Injection Treatments
ACTEMRA is a prescription medicine used to treat adults with moderately to severely active rheumatoid arthritis (RA).
ADAKVEO is a prescription medicine used in people 16 years of age and older who have sickle cell disease to help reduce how often painful crises happen.
AMVUTTRA is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
AVSOLA® is a biosimilar of the biologic medicine Remicade® (infliximab). Your doctor may prescribe AVSOLA® to treat your chronic inflammation disease.
BENLYSTA® (Belimumab) is an immunosuppressive drug used to treat active Systemic Lupus Erythematosus.
BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
CIMZIA® (Certolizumab pegol) is an anti-inflammatory drug used to treat various autoimmune diseases.
CEREZYME® is the ONLY ERT (enzyme replacement therapy) that has shown long-term efficacy and safety in multiple studies over 20 years and has been prescribed for over 25 years.
ENTYVIO® (Vedolizumab) is an anti-inflammatory drug used to treat Inflammatory Bowel Diseases.
FABRAZYME® (Agalsidase beta) is used in the treatment of Fabry Disease by replacing a missing enzyme that lowers the amount of GL-3 being deposited in the lining of blood vessels.
FASENRA® (Benralizumab) is an immunosuppressive drug that is used as an add-on maintenance therapy for patients with severe Eosinophilic Asthma.
GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP)
ILUMYA® is a biologic treatment used for moderate-to-severe plaque psoriasis. It’s an injection that works within the body to balance an overactive immune system, addressing the symptoms at the source for the long haul.
Intralipid® is used as a source of calories and essential fatty acids to help treat a wide array of diseases.
Immune globulin (IG) therapy is used to treat the following conditions: Primary Immunodeficiency, Multifocal Motor Neuropathy, Primary Humoral
KRYSTEXXA® (Pegloticase) is a drug used in the treatment of severe, refractory, chronic gout. It metabolizes uric acid to allantoin making it more water soluble increasing its excretion.
Lemtrada® (Alemtuzumab) is a medication used to treat adults with relapsing forms of multiple sclerosis (MS).
LEQVIO (inclisiran) is an injectable prescription medicine used along with diet and other lipid-lowering medicines in adults who need additional lowering of "bad" cholesterol (LDL-C) and have known cardiovascular disease and/or heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high levels of LDL-C.
NAD+ stands for nicotinamide adenine dinucleotide, and it is a coenzyme found in all living cells. It is considered to be an anti-aging molecule, and it promotes a healthy lifestyle and a prolonged lifespan
NEXVIAZYME is the first new enzyme replacement therapy for late-onset Pompe disease (LOPD) in 15 years. It’s designed to bind to muscle cells with a high affinity (a strong attachment). After this happens, NEXVIAZYME enters the cells, so it can help break down glycogen.
Nulojix is a biologic infusion therapy that helps prevent transplant rejection in adults who have received a kidney transplant.
OCREVUS® (Ocrelizumab) is an immunosuppressive drug used in the treatment of Relapsing and Primary Progressive Multiple Sclerosis.
ONPATTRO® (Patisiran) is a double-stranded small interfering ribonucleic acid targeted to hepatocytes for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
ORENCIA® (Abatacept) is an immunosuppressive drug used in the treatment of various types of arthritis.
RADICAVA® (Edaravone) is a prescription drug used for the treatment of Amyotrophic Lateral Sclerosis.
REMICADE, Infliximab, is an immunosuppressive drug that is used in the treatment of Inflammatory Bowel Disease, as well as other autoimmune diseases. Administration of REMICADE follows an induction regimen of 3 intravenous infusions at week 0, 2, and 6 followed by a maintenance infusion then every 8 weeks for maintenance.
RENFLEXIS® (Infliximab-abda) a biosimilar to Remicade, is a drug used in the treatment of Inflammatory Bowel Disease, as well as other autoimmune diseases.
RITUXAN® (Rituximab) is a prescription medicine used to treat adults with various forms of immunodeficient diseases.
RUXIENCE is an FDA-approved biosimilar to Rituxan® (rituximab)
SIMPONI ARIA® (Golimumab) is an immunosuppressive drug that reduces the body’s inflammation to treat various autoimmune diseases.
SKYRIZI can help control symptoms for Plaque Psoriasis, Psoriatic Arthritis and Chron's Disease.
Soliris® (Eculizumab) is a monoclonal antibody in the category of immunosuppressive drugs used for the treatment of hemolytic blood disorders.
SOLU-MEDROL® (Methylprednisolone) is a steroid that is intravenously administered for the treatment of inflammation, severe allergies and flares of chronic illnesses.
STELARA IV® (Ustekinumab) is an immunosuppressive drug that reduces inflammation in the body due to various autoimmune diseases.
STELARA SQ® (Ustekinumab) is an immunosuppressive drug that reduces inflammation in the body due to various autoimmune diseases.
TEPEZZA® (teprotumumab-trbw) is a prescription medicine used in the treatment of Thyroid Eye Disease (TED). It reduces the signs and symptoms of TED, including eye bulging, double vision, eye pain, redness, and swelling.
TEZSPIRE is an add-on maintenance treatment for people aged 12 and older with severe asthma. TEZSPIRE is not a rescue medication.
TRUXIMA is a prescription drug used in adults to treat NHL and CLL.
TYSABRI® (Natalizumab) is a prescription medicine used to treat adults with relapsing forms of Multiple Sclerosis.
ULTOMIRIS is a medicine that affects your immune system and can lower the ability of your immune system to fight infections.
UPLIZNA is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.
VPRIV® (Velaglucerase alfa) is a long-term enzyme replacement therapy for patients with type 1 Gaucher disease.
VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.
VYVGART is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
XENPOZYME (olipudase alfa-rpcp) is indicated for treatment of non–central nervous system manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients.
XOLAIR® (Omalizumab) is an immunosuppressive drug used to treat moderate to severe persistent allergic asthma not controlled by inhaled corticosteroids.